Clover Health Investments, Corp. (CLOV) CEO Vivek Garipalli on Q1 2021 Results - Earnings Call Transcript

Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2021 Earnings Conference Call May 17, 2021 8:30 AM ET

Company Participants

Derrick Nueman - Head of IR and Corporate Strategy
Vivek Garipalli - CEO
Andrew Toy - President
Joe Wagner - CFO

Conference Call Participants

Kevin Fischbeck - Bank of America
Jailendra Singh - Credit Suisse
Lisa Gill - JPMorgan

Operator

Good day and thank you for standing by. Welcome to the Clover Health's First Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' prepared remarks, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]

I would now like to hand the conference over to your speaker for today, Derrick Nueman, Head of Investor Relations and Corporate Strategy. Please go ahead.

Derrick Nueman

Good morning, everyone. I want to introduce myself as this is the first earnings call as the Head of Investor Relations and Corporate Strategy at Clover. And I wanted to express how excited I am about the opportunity here, as well as Clover's opportunity to make healthcare better. With that out of the way, thank you for joining our call today, where our CEO, Vivek Garipalli; our President, Andrew Toy; and our CFO, Joe Wagner, will discuss first quarter results and answer your questions. Note, this call is being recorded.

I'd also like to caution you that we may make forward-looking statements during today's call that are subject to risks and uncertainties. Factors that may cause actual results to differ materially from expectations are detailed in our SEC filings including the Form 8-K filed today containing our earnings release. Information about any non-GAAP financial measures referenced, including a reconciliation of those measures to GAAP measures can also be found in our SEC filings and the